Expressing the sense of the House of Representatives concerning the need for further studies and accurate guidelines regarding the use of mammograms and other technology to screen women between the ages of 40 and 49 for breast cancer.

Expresses the sense of the House of Representatives that studies are needed to further determine the benefits of screening women between the ages of 40 and 49 for breast cancer through mammograms and other emerging technologies and that the House urges the Advisory Panel for the National Cancer Institute to: (1) consider reissuing a specified guideline rescinded in 1993; or (2) direct the public to consider guidelines issued by other organizations until there is more definitive data.